2024 HCPCS Code M1194

Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)

TAGS: tests neoadjuvant included recommendation impression inhibitor patient status residual testing tumor conclusion exhausted contain surgical documentation checkpoint present medical treated pathology reports sample insufficient carcinoma

Short DescriptionMed rsn no imp/con mmr/msi
HCPCS Coverage Code C - Carrier judgment
HCPCS Action Code N - No maintenance for this code
HCPCS Action Effective Date January 01, 2023
HCPCS Code Added Date January 01, 2023
HCPCS Pricing Indicator Code 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.)
HCPCS Multiple Pricing Indicator Code 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99')
HCPCS Coverage Issues Manual Reference Section Number
HCPCS Type Of Service Code 1 - Medical care
HCPCS Anesthesia Base Unit Quantity 0

Check Similar HCPCS Codes